Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2017-04, Vol.31 (4), p.988-991
Hauptverfasser:	Rossille, D, Azzaoui, I, Feldman, A L, Maurer, M J, Labouré, G, Parrens, M, Pangault, C, Habermann, T M, Ansell, S M, Link, B K, Tarte, K, Witzig, T E, Lamy, T, Slager, S L, Roussel, M, Milpied, N, Cerhan, J R, Fest, T
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1990/291/1621/1915 692/308/575 692/4028/67/1059/99 692/53/2422 692/700/1750 82/80 Adolescent Adult Aged Aged, 80 and over Apoptosis B-cell lymphoma Biomarkers Biomarkers, Tumor - metabolism Cancer Cancer Research Cancer therapies Cells Critical Care Medicine Female Hematology Human health and pathology Humans Immunotherapy Intensive Internal Medicine letter-to-the-editor Letters to the editor Leukemia Life Sciences Ligands Lymphocytes B Lymphoma Lymphoma, Large B-Cell, Diffuse - metabolism Lymphoma, Large B-Cell, Diffuse - pathology Male Medical prognosis Medicine Medicine & Public Health MicroRNAs Middle Aged Oncology Prognosis Programmed Cell Death 1 Receptor - metabolism Protein expression Proteins Tumor Microenvironment - physiology Vitamin D Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!